Search research articles
Contact Us
Filters
Showing results (181-190 of 202) with videos related to
Page
of 21
Sort By:
The American Journal of Cardiology
|
October 6, 2021
Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease
Tae Oh Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
Journal of Gastroenterology and Hepatology
|
July 9, 2013
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective study
Kang-Moon Lee, Yoon Tae Jeen, Ju Yeon Cho, et al.
Inflammatory Bowel Diseases
|
January 27, 2021
Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study
Jeongseok Kim, Hyuk Yoon, Nayoung Kim, et al.
Archives of Pharmacal Research
|
May 30, 2014
A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
Oh Young Lee, Dae-Hwan Kang, Dong Ho Lee, et al.
Korean Circulation Journal
|
November 27, 2024
Safety and Efficacy of Pivot-Balloon for Severe Tricuspid Regurgitation: The First-in-Man Experiences
Eun Kyoung Kim, Min-Ku Chon, Hyun-Sook Kim, et al.
International Journal of Molecular Sciences
|
April 17, 2025
Early Progression Prediction in Korean Crohn's Disease Using a Korean-Specific PrediXcan Model
Tae-Woo Kim, Soo Kyung Park, Jaeyoung Chun, et al.
The Lancet. Gastroenterology & Hepatology
|
October 3, 2025
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Kaichun Wu, Changqing Zheng, Qian Cao, et al.
Lipids
|
April 18, 2025
Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial
Tae Oh Kim, Kyounghoon Lee, Jin-Man Cho, et al.
World Journal of Gastroenterology
|
March 26, 2015
Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents
Eun Soo Kim, Geun Am Song, Kwang Bum Cho, et al.
Gut and Liver
|
June 22, 2022
A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
Su Hyun Park, Kang Nyeong Lee, Oh Young Lee, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 202) with videos related to
Sort By:
Page
of 21
The American Journal of Cardiology
|
October 6, 2021
Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease
Tae Oh Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
Journal of Gastroenterology and Hepatology
|
July 9, 2013
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective study
Kang-Moon Lee, Yoon Tae Jeen, Ju Yeon Cho, et al.
Inflammatory Bowel Diseases
|
January 27, 2021
Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study
Jeongseok Kim, Hyuk Yoon, Nayoung Kim, et al.
Archives of Pharmacal Research
|
May 30, 2014
A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment
Oh Young Lee, Dae-Hwan Kang, Dong Ho Lee, et al.
Korean Circulation Journal
|
November 27, 2024
Safety and Efficacy of Pivot-Balloon for Severe Tricuspid Regurgitation: The First-in-Man Experiences
Eun Kyoung Kim, Min-Ku Chon, Hyun-Sook Kim, et al.
International Journal of Molecular Sciences
|
April 17, 2025
Early Progression Prediction in Korean Crohn's Disease Using a Korean-Specific PrediXcan Model
Tae-Woo Kim, Soo Kyung Park, Jaeyoung Chun, et al.
The Lancet. Gastroenterology & Hepatology
|
October 3, 2025
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Kaichun Wu, Changqing Zheng, Qian Cao, et al.
Lipids
|
April 18, 2025
Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial
Tae Oh Kim, Kyounghoon Lee, Jin-Man Cho, et al.
World Journal of Gastroenterology
|
March 26, 2015
Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents
Eun Soo Kim, Geun Am Song, Kwang Bum Cho, et al.
Gut and Liver
|
June 22, 2022
A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
Su Hyun Park, Kang Nyeong Lee, Oh Young Lee, et al.
Page
of 21